Discovery of Novel Aryl Triazolone Dihydropyridines (ATDPs) Targeting Highly Conserved Residue W229 as Promising HIV-1 NNRTIs-Reference-Cited by-同舟云学术

Discovery of Novel Aryl Triazolone Dihydropyridines (ATDPs) Targeting Highly Conserved Residue W229 as Promising HIV-1 NNRTIs

Published:2024-04-13 Issue:8 Volume:67 Page:6570-6584
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Sun Yanying¹,Zhou Zhenzhen¹,Wang Na¹,Zhao Fabao¹,Liu Ying¹,Xu Xiaoxuan¹,Wang Xiaohan¹,Gou Zhenbang¹,De Clercq Erik²^ORCID,Pannecouque Christophe²,Zhan Peng¹³^ORCID,Kang Dongwei¹³^ORCID,Liu Xinyong¹³^ORCID

Affiliation:

1. Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, 44 West Culture Road ,Jinan ,Shandong 250012, P.R. China

2. Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, K.U. Leuven, Herestraat 49 Postbus 1043 (09.A097), Leuven B-3000, Belgium

3. China-Belgium Collaborative Research Center for Innovative Antiviral Drugs of Shandong Province, Jinan 250012, P.R. China

Funder

National Key Research and Development Program of China

China Postdoctoral Science Foundation

Taishan Scholar Foundation of Shandong Province

Shandong University

National Natural Science Foundation of China

Natural Science Foundation of Shandong Province

Foreign Cultural and Educational Experts Project

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.4c00026

Reference22 articles.

1. HIV infection

2. WHO. HIV/AIDS. https://www.who.int/news-room/factsheets/detail/hiv-aids (accessed Mar 29, 2023).

3. Highly Active Antiretroviral Therapy Decreases Mortality and Morbidity in Patients with Advanced HIV Disease

4. Structure-Based Bioisosterism Yields HIV-1 NNRTIs with Improved Drug-Resistance Profiles and Favorable Pharmacokinetic Properties

5. The Journey of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) from Lab to Clinic